Association of Environmental Cadmium Exposure with Periodontal Disease in U.S. Adults by Arora, Manish et al.
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 5 | May 2009  739
Research
Periodontal disease is a common, multi- 
factorial, chronic inflammatory disease that 
involves degradation of tissues that support 
teeth, including alveolar bone (jaw bone) 
(Pihlstrom et al. 2005). Colonization by pre-
dominantly gram-negative bacteria arising 
from dental plaque stimulates an inflamma-
tory response that in some individuals, results 
in the breakdown of the connective tissue 
surrounding teeth (Preshaw et al. 2004). 
Periodontal disease can lead to tooth loss in 
adults and has been linked to a number of 
systemic disorders such as cardiovascular dis-
ease, stroke, and preterm birth (Pihlstrom 
et al. 2005). Although environmental factors 
have been implicated as possible risk factors 
(Barbour et al. 1997; Saraiva et al. 2007), the 
role of environmental toxins in the etiology of 
this disease has received limited attention.
Cadmium is a ubiquitous toxicant in our 
environment, and an estimated 2.3% of the 
U.S. population has elevated levels of urine 
cadmium (> 2 µg/g creatinine), a marker of 
chronic exposure and body burden (Paschal 
et al. 2000). Human exposure to Cd is pos-
sible from a number of sources, with smok-
ing being a major contributor (Paschal et al. 
2000). Other sources of Cd include emissions 
from industrial activities, including min-
ing, smelting, and manufacturing of batter-
ies, pigments, stabilizers, and alloys [Agency 
for Toxic Substances and Disease Registry 
(ATSDR) 2008]. Cadmium is also present in 
trace amounts in certain foods such as leafy 
vegetables, potatoes, grains and seeds, liver and 
kidney, and crustaceans and mollusks (Satarug 
et al. 2003). Once in the body, Cd accumu-
lates in the kidney and liver and is excreted 
slowly over several years (ATSDR 2008).
The pathologic effects of Cd on bone, 
including the ability to promote inflamma-
tion, are pertinent to periodontal disease, 
where disruption of the host inflammatory 
response is considered a primary factor in 
disease progression and subsequent alveolar 
bone loss. The adverse effects of Cd expo-
sure on bone are well established (Järup 
2003; Kazantzis 2004). Several epidemio-
logic studies have documented an associa-
tion of chronic low-level Cd exposure with 
decreases in bone mineral density (BMD) 
and osteoporosis (Åkesson et al. 2006; Alfvén 
et al. 2000; Gallagher et al. 2008; Honda 
et al. 2003; Schutte et al. 2008; Staessen et al. 
1999). Data from experimental models sug-
gest that Cd disrupts the bone remodeling 
process, decreases skeletal mineralization, and 
enhances bone loss (Brzóska and Moniuszko-
Jakoniuk 2004). Cadmium exposure has also 
been shown to stimulate, in a number of cell 
types and tissues, the production of pros-
tanoids (e.g., prostaglandin E2), cytokines 
[e.g., interleukins, tumor necrosis factor-α 
(TNF-α)], and matrix metalloproteinases 
(MMP) (Hemdan et al. 2006; Kirschvink 
et al. 2005; Marth et al. 2000, 2001; Romare 
and Lundholm 1999; Suzuki et al. 1989).
Based on this evidence, our hypothesis 
was that, because of its ability to promote 
inflammation and affect the bone remodel-
ing process, environmental Cd exposure may 
be associated with periodontal disease. We 
used data from the third National Health and 
Nutrition Examination Survey (NHANES 
III), a nationally representative survey con-
ducted from 1988 through 1994 in the 
United States. We placed particular emphasis 
on accounting for exposures to environmental 
tobacco smoke (ETS), which may potentially 
confound the observed association between 
Cd and periodontal disease.
Materials and Methods
Study participants. NHANES III identified 
39,695 persons for sampling, of whom 33,994 
were interviewed and 30,818 attended the 
mobile examination center [National Center 
for Health Statistics (NCHS) 1996]. Dentate 
individuals who were ≥ 13 years of age and 
who lacked medical contraindications (n = 
28,059) were eligible for periodontal assess-
ments (Westat, Inc. 1992). For the present 
study, we were interested in adult periodon-
tal disease and included only participants 
≥ 18 years of age (n = 17,752). Among these, 
we excluded participants who had no peri-
odontal assessment or a partial assessment 
(n = 3,347) or invalid laboratory measurements 
of urine Cd (n = 912) or of serum cotinine (a 
Address correspondence to M. Arora, Environmental 
and Occupational Medicine and Epidemiology, 
Harvard School of Public Health, Landmark Center 
East 3-112-4, 401 Park Dr., Boston, MA 02215 
USA. Telephone: (617) 384-8737. Fax: (617) 384-
8994. E-mail: marora@hsph.harvard.edu
Supplemental Material is available online at http://
www.ehponline.org/members/2009/0800312/suppl.pdf
The authors declare they have no competing 
  financial interests.
Received 22 October 2008; accepted 21 January 
2009.
Association of Environmental Cadmium Exposure with Periodontal Disease 
in U.S. Adults
Manish Arora,1,2 Jennifer Weuve,2,3 Joel Schwartz,2 and Robert O. Wright 2,4
1Population Oral Health, Faculty of Dentistry, Westmead Centre for Oral Health, University of Sydney, Sydney, New South Wales, 
Australia; 2Environmental and Occupational Medicine and Epidemiology, Department of Environmental Health, Harvard School of 
Public Health, Boston, Massachusetts, USA; 3Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA; 
4Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Ba c k g r o u n d: Periodontal disease is a complex, multifactorial, chronic inflammatory disease that 
involves degradation of periodontal structures, including alveolar bone. Cadmium adversely affects 
bone remodeling, and it is therefore possible that environmental Cd exposure may be a risk factor 
for periodontal-disease–related bone loss.
oB j e c t i v e: We examined the relationship between environmental Cd exposure and perio  dontal 
disease in U.S. adults.
Me t h o d s : We analyzed cross-sectional data from the third National Health and Nutrition 
Examination Survey (NHANES III). We defined periodontal disease as clinical attachment loss of at 
least 4 mm in > 10% of sites examined. We used multivariable-adjusted logistic regression analyses 
to estimate the association between creatinine-corrected urinary Cd levels and periodontal disease.
re s u l t s: Of the 11,412 participants included in this study, 15.4% had periodontal disease. The age-
adjusted geometric mean urine Cd concentration (micrograms per gram creatinine) was significantly 
higher among participants with periodontal disease [0.50; 95% confidence interval (CI), 0.45–0.56] 
than among those without periodontal disease (0.30; 95% CI, 0.28–0.31). Multivariable-adjusted 
analyses, which included extensive adjustments for tobacco exposure, showed that a 3-fold increase 
in creatinine-corrected urinary Cd concentrations [corresponding to an increment from the 25th 
(0.18 µg/g) to the 75th (0.63 µg/g) percentile] was associated with 54% greater odds of prevalent 
periodontal disease (odds ratio = 1.54; 95% CI, 1.26–1.87). We observed similar results among the 
subset of participants who had limited exposure to tobacco, but only after removing six influential 
observations.
co n c l u s i o n: Environmental Cd exposure was associated with higher odds of periodontal disease.
key w o r d s : environmental tobacco smoke, NHANES III, periodontal disease, smoking, urine 
cadmium. Environ Health Perspect 117:739–744 (2009).  doi:10.1289/ehp.0800312 available via 
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biomarker of exposure to ETS; n = 1,555). 
We further excluded pregnant (n = 264) and 
breast-feeding women (n = 100) to avoid the 
effects of increased bone remodeling and also 
transient changes to periodontal tissues during 
these periods (Kalkwarf and Specker 2002; 
Laine 2002; Sowers 1996). Overall, our study 
population included 11,412 participants.
Urine Cd and creatinine measurements. 
Details of the urine collection and Cd analysis 
have been reported previously (Paschal et al. 
2000). Briefly, during the physical examina-
tion, a 10-mL spot sample of urine was col-
lected from survey participants. Cadmium was 
quantified by Zeeman effect graphite furnace 
atomic absorption spectrophotometry with 
a detection limit of approximately 0.01 ng/
mL (NCHS 2006). Each sample was analyzed 
in duplicate, and mean measurements were 
reported. Specimens with Cd concentrations 
> 6 ng/mL were reanalyzed for confirmation 
(Paschal et al. 2000). We used creatinine- 
corrected urine Cd concentrations (micrograms 
Cd per gram of creatinine) in our analyses.
Periodontal examination. Details of the 
periodontal examinations have been previ-
ously described (Westat, Inc. 1992). Briefly, 
six trained and calibrated dentists examined a 
maximum of seven teeth of the upper jaw in 
a randomly selected half-mouth (quadrant). 
Similarly, a maximum of seven lower teeth 
were also examined in a randomly selected 
lower quadrant, giving a maximum possible 
total of 14 teeth examined per participant. 
Clinical measurements of periodontal disease 
were done at two sites (mesiobuccal and buc-
cal) for each tooth. We focused our analysis on 
clinical attachment loss, which is a measure of 
the amount of periodontal tissue lost because 
of the disease process. In NHANES III, clini-
cal attachment loss was the distance from the 
cementoenamel junction (CEJ) to the base of 
the sulcus measured (in millimeters) using a 
National Institute of Dental Research (NIDR) 
periodontal probe (Figure 1). We calculated 
this distance by subtracting from the pocket 
depth, the distance from the gingival mar-
gin to the CEJ. We used a case definition of 
periodontitis as attachment loss of ≥ 4 mm in 
> 10% of sites examined.
Assessment of tobacco exposure. Because 
cigarette smoke is a major source of Cd in U.S. 
adults (Paschal et al. 2000) and is also associated 
with an increased risk of periodontal disease 
(Tomar and Asma 2000), we considered it an 
important potential confounder of any observed 
association between Cd exposure and periodon-
tal disease. We incorporated into our study two 
assessments of cigarette smoking. First, we used 
serum cotinine, a biomarker of both active and 
passive exposure to cigarette smoke. Serum coti-
nine was measured using isotope-dilution liquid 
chromatography with tandem mass spectrom-
etry (Bernert et al. 1997), with a limit of detec-
tion of 0.05 ng/mL (NCHS 2006). Second, we 
used pack-years of cigarette smoking, calculated 
by multiplying the reported average number of 
cigarettes smoked daily by the reported number 
of years smoked and dividing this product by 
20 (cigarettes per pack). In addition to ciga-
rette smoking, we used questionnaire-recorded 
responses to categorize participants as never, 
past, or current users of chewing tobacco, pipes, 
and cigars. To estimate ETS exposure, we used, 
in addition to serum cotinine, the response to a 
questionnaire item: “At work, how many hours 
per day are you close enough to people who 
smoke so that you can smell the smoke?” To 
account for potential exposure to ETS at home, 
we included the number of smokers at the par-
ticipant’s home (0 vs. ≥ 1) in our analyses.
Diabetes, BMD, and urinary albumin 
measurements. We included in our analy-
ses certain systemic conditions that may 
be potential confounders because of their 
reported associations with both Cd expo-
sure and periodontal disease. We classified a 
participant as having type 2 diabetes if he or 
she reported a physician diagnosis of diabetes 
(other than during pregnancy), reported tak-
ing prescription medications (either insulin 
or oral agents) for diabetes, had a nonfasting 
plasma glucose ≥ 11.1 mmol/L (200 mg/dL), 
had a fasting plasma glucose ≥ 7.0 mmol/L 
(126 mg/dL), or had a glycosylated hemoglo-
bin (HbA1c) measurement > 6.1% (Perlstein 
et al. 2008; Rohlfing et al. 2000).
Because studies have previously reported 
associations between osteoporosis and peri-
odontal disease (Wactawski-Wende 2001), we 
also included in our analyses total hip BMD 
measurements to adjust for osteopenia and 
osteoporosis. NHANES III measured BMD 
using a dual-energy X-ray absorptiometry 
instrument (QDR 1000; Hologic, Waltham, 
MA, USA), and verified data quality in a 
quality control program (Wahner et al. 1994). 
Urinary albumin concentrations were meas-
ured using a solid-phase fluorescent immuno-
assay (Gunter et al. 1996). Urinary albumin 
concentrations were dichotomized at 30 µg/
mL because concentrations above this level are 
considered indicative of renal damage (Paschal 
et al. 2000).
Statistical analysis. We examined sum-
mary statistics and scatter plots for key vari-
ables to identify outliers. We also studied 
age-adjusted geometric mean urine Cd con-
centrations [age standardized to the 2000 
U.S. census population using age categories 
of 18–39, 40–59, and ≥ 60 years (Klein and 
Schoenborn 2001)] and periodontitis within 
key subject characteristics. Subsequently, we 
used multivariable-adjusted logistic regression 
to estimate the prevalence odds ratio (OR) of 
having periodontal disease for increments in 
loge-transformed, creatinine-corrected urinary 
Cd concentration. We report our results as 
ORs for a 3-fold increase in urinary Cd [i.e., 
exp(β
^
loge[Cd] × ln[3])], which corresponds to 
an increment in urine Cd concentration from 
the 25th to the 75th percentile. The principal 
models incorporated variables previously asso-
ciated with periodontal disease, including age 
(years), sex, education of head of household 
(< high school, some high school, or > high 
school), ethnicity (non-Hispanic white, non-
Hispanic black, Mexican American, other), 
household income (≥ 100% of federal poverty 
line or < 100% of federal poverty line), serum 
cotinine (nanograms per milliliter), cigarette 
smoking (0, > 0 to 9.9, ≥ 10 pack-years), 
chewing tobacco (never, past, current user), 
pipe smoking (never, past, current user), cigar 
smoking (never, past, current user), number of 
smokers at home (0 vs. ≥ 1), exposure to ETS 
at work (yes vs. no), number of teeth missing, 
BMD (grams per square centimeters), urine 
albumin (≤ 30 µg/mL vs. > 30 µg/mL), blood 
lead level (micrograms per deciliter), and type 
2 diabetes (yes vs. no). We included survey 
phase and examiner identification numbers 
(coded 1 to 6) in the model to adjust for dif-
ferences between survey phases and variations 
in the measurements of periodontitis (Slade 
and Beck 1999).
We were concerned that the observed 
association between Cd and periodontal dis-
ease may be confounded by active or passive 
exposure to tobacco. We therefore under-
took parallel analyses restricted to participants 
with limited tobacco exposure (never-users of 
cigarettes, pipes, cigars, and chewing tobacco; 
no reported smoker at home; no reported 
exposure to smoke at work; serum cotinine 
concentrations ≤ 10 ng/mL). Furthermore, 
we were also concerned that the markers of 
systemic conditions (diabetes, BMD, urinary 
albumin) we included in our analyses may 
not be confounders but rather intermediates 
Figure 1. Diagram comparing healthy periodontal 
tissues with those affected by periodontal disease. 
In NHANES III, clinical attachment loss (AL) was 
the distance from the CEJ to the base of the sulcus 
measured in millimeters using an NIDR periodontal 
probe. We calculated this distance by subtracting 
from the pocket depth (PD) the distance from the 
gingival margin to the CEJ.
Normal Periodontitis
Sulcus
Gingival
margin
CEJ
Periodontal pocket
PD
AL
BoneCadmium and periodontal disease
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in the relation of Cd exposure to periodon-
tal disease. We, therefore, undertook addi-
tional analyses excluding these variables from 
our logistic regression model to determine 
if their exclusion would alter the observed 
association between Cd and periodontal dis-
ease. We also excluded missing teeth vari-
ables from this analysis because tooth loss 
may be a consequence of periodontal disease 
rather than a confounder. Blood lead has 
previously been associated with periodontal 
disease, so we undertook analyses restricted 
to participants with blood lead concentra-
tions < 3 µg/dL, which was the median 
blood lead concentration in our participants. 
For all data analyses, we used SAS version 
9.1 (SAS Institute Inc., Cary, NC, USA) 
and accounted for the complex multistage 
sampling design of NHANES III. For our 
multivariable-adjusted logistic regression 
analyses, we used DFBETA (or Δβ) to iden-
tify observations that unduly influenced the 
parameter estimates for creatinine-corrected 
urinary Cd concentration [see Supplemental 
Material for details (http://www.ehponline.
org/members/2009/0800312/suppl.pdf)]. We 
identified influential points separately in mod-
els for the full cohort and the low-tobacco 
group and provide results for analyses that 
excluded these observations as well as results 
when we retained these data.
Results
The median creatinine-corrected urine Cd 
concentration of the participants in our study 
was 0.34 µg/g creatinine, with the 5th and 
95th percentiles being 0.03 and 1.37 µg/g 
creatinine, respectively. The participants in 
our study were 40.9 years of age, on average 
(standard deviation = 17.2), and 52.3% were 
female. Approximately 15% (n = 1,758) of 
participants exhibited periodontal disease, as 
defined by the presence of attachment loss 
of at least 4 mm in > 10% of sites examined. 
Urinary Cd levels tended to be higher among 
participants who were female, were older, 
had lower levels of formal education, were 
of non-Hispanic black race/ethnicity, or had 
a household income below the federal pov-
erty line (Table 1). Indicators of exposure to 
tobacco—including cigarette smoking, serum 
cotinine, and exposure to cigarette smoke at 
home and work—were positively associated 
with age-adjusted urinary Cd concentrations. 
We observed no remarkable associations 
between age-adjusted urinary Cd concentra-
tions and pipe, cigar, or chewing tobacco use. 
Blood lead, urine albumin, having type 2 dia-
betes, and missing teeth were positively associ-
ated with urinary Cd concentrations, whereas 
BMD was inversely associated with urine Cd. 
Notably, participants with periodontal disease 
had significantly higher age-adjusted urinary 
Cd concentrations than those without peri-
odontal disease (Table 1).
Similar to another report of periodontal 
disease in NHANES III (Borrell et al. 2005), 
cases of periodontal disease were significantly 
more prevalent among participants who were 
male, were older, had less formal education, 
or had a lower household income (data not 
shown). A significantly higher proportion 
of current smokers had periodontal disease 
compared with past- or never-smokers, and 
the prevalence of periodontal disease was also 
Table 1. Distribution of age-adjusteda geometric mean urinary Cd concentrations by participant characteristics: NHANES III (1988–1994).
aAge-standardized to the 2000 U.S. census population using age categories of 18–39, 40–59, and > 60 years (Klein and Schoenborn 2001).bParticipants ≥18 years of age. cNumbers of sub-
jects differ because of missing data. dPeriodontal disease defined as having at least 4 mm of clinical attachment loss in > 10% of sites examined. eNot adjusted for age.
  No. of participantsb, c  µg Cd/g creatinine
Characteristic   (unweighted)  (95% CI)
Periodontal diseased  
  No  9,654  0.30 (0.28–0.31)
  Yes  1,758   0.50 (0.45–0.56)
Sex   
  Male  5,602  0.26 (0.24–0.28)
  Female  5,810  0.37 (0.35–0.40)
Age (years)e  
  18–29  3,460  0.15 (0.15–0.16)
  30–39  2,671  0.29 (0.28–0.30)
  40–49  1,990  0.39 (0.38–0.41)
  50–59  1,042  0.49 (0.46–0.52)
  ≥ 60   2,168  0.57 (0.55–0.59)
Education level of household head   
  < High school  2,251  0.35 (0.32–0.39)
  High school  5,089  0.36 (0.33–0.39)
  > High school  3,663  0.27 (0.26–0.29)
Race/ethnicity   
  Non-Hispanic white  4,108  0.30 (0.28–0.32)
  Non-Hispanic black  3,246  0.36 (0.35–0.38)
  Mexican American  3,589  0.32 (0.31–0.34)
  Other  469  0.34 (0.29–0.39)
Household poverty status   
  < Federal poverty line  7,961  0.39 (0.36–0.43)
  ≥ Federal poverty line  2,454  0.30 (0.29–0.32)
Time since last visit to dentist (years)   
  ≤ 1  7,424  0.30 (0.29–0.32)
  > 1  3,927  0.33 (0.31–0.36)
Missing teeth   
  None  3,856  0.25 (0.23–0.27)
  1–10  6,630  0.35 (0.33–0.37)
  > 10  926  0.52 (0.47–0.58)
Serum cotinine, ng/mL   
  < 0.05 (detection limit)  1,285  0.24 (0.21–0.27)
  0.05–10  6,811  0.27 (0.26–0.29)
  > 10–100  895  0.28 (0.25–0.32)
  > 100–250  1,175  0.46 (0.41–0.50)
  ≥ 250  1,246  0.58 (0.54–0.62)
  No. of participantsb, c  µg Cd/g creatinine
Characteristic   (unweighted)  (95% CI)
Pack-years of cigarette smoking   
  0  6,098  0.24 (0.23–0.26)
  > 0–9.9  2,338  0.30 (0.27–0.32)
  ≥ 10  2,565  0.54 (0.51–0.57)
No. of cigarette smokers at home   
  0  7,320  0.27 (0.25–0.28)
  ≥ 1  4,082  0.42 (0.40–0.45)
Exposure to smoke at work   
  No  4,435  0.27 (0.25–0.28)
  Yes  2,885  0.33 (0.30–0.37)
Chewing tobacco   
  Never-user  10,570  0.32 (0.30–0.33)
  Past user  385  0.32 (0.28–0.35)
  Current user  273  0.28 (0.23–0.34)
Pipe   
  Never-smoker  10,656  0.31 (0.30–0.33)
  Past smoker  684  0.38 (0.34–0.42)
  Current smoker  65  0.38 (0.24–0.59)
Cigars    
  Never-smoker  10,348  0.32 (0.30–0.33)
  Past smoker  898  0.31 (0.28–0.35)
  Current smoker  161  0.28 (0.21–0.38)
Blood lead [quartiles (µg/dL)]   
  < 1.7  2,969  0.27 (0.25–0.29)
  1.7–2.8  2,853  0.28 (0.26–0.31)
  2.9–4.6  2,737  0.33 (0.30–0.35)
  > 4.6  2,836  0.41 (0.39–0.44)
Diabetes   
  No  9,940  0.31 (0.29–0.33)
  Yes  1,357  0.38 (0.35–0.42)
Renal dysfunction    
  No (urine albumin ≤ 30 µg/mL)  10,148  0.31 (0.29–0.32)
  Yes (urine albumin > 30 µg/mL)  1,263  0.39 (0.35–0.43)
Bone mineral density [quartiles (g/cm2)]   
  < 0.87  2,482  0.36 (0.33–0.40)
  0.87–0.97  2,503  0.34 (0.32–0.37)
  0.98–1.08  2,501  0.28 (0.26–0.30)
  > 1.08  2,514  0.26 (0.24–0.28)Arora et al.
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significantly higher with increasing serum 
cotinine concentrations (data not shown).
Using multivariable-adjusted logistic 
regression analyses, we observed that, for a 
3-fold increment in creatinine-corrected uri-
nary Cd concentrations [equivalent to the 
increment from the 25th (0.18 µg/g creatinine) 
to the 75th (0.63 µg/g creatinine) percentile in 
urinary Cd], the odds of having periodontal 
disease increased by 54% [OR = 1.54; 95% 
confidence interval (CI), 1.26–1.87; Table 2]. 
In this model, increasing age, male sex, having 
less than high school education, non-Hispanic 
black race/ethnicity, and household income 
below the federal poverty line were also signifi-
cantly associated with increased odds of having 
periodontal disease. Participants who indicated 
up to 9.9 pack-years of smoking had increased 
odds for periodontal disease (OR = 1.67; 
95% CI, 1.06–2.61) compared with never-
smokers, an association similar to that for par-
ticipants reporting 10 or more pack-years of 
smoking (OR = 1.44; 95% CI, 0.92–2.26). 
Diabetes and having missing teeth were also 
associated with increased odds of periodon-
titis. As expected, when all tobacco variables 
were excluded from our analyses, the asso-
ciation between urinary Cd and peri  odontal 
disease was notably stronger (OR = 1.87; 
95% CI, 1.54–2.26).
In analyses restricted to participants with 
blood lead concentrations < 3 µg/dL, the asso-
ciation between urine Cd concentrations and 
periodontal disease remained significant (OR 
= 2.09; 95% CI, 1.39–3.13). In other analyses 
that excluded diabetes, BMD, renal dysfunc-
tion, and number of missing teeth, the asso-
ciation between Cd and periodontal disease 
remained nearly identical to the fully adjusted 
results (per tripling in creatinine-corrected 
urinary Cd: OR = 1.52; 95% CI, 1.25–1.85; 
Table 2). When the analysis was restricted 
to participants with low tobacco exposure, a 
3-fold increase in urinary Cd concentrations 
corresponded to a 68% increase in the odds 
of having periodontal disease (OR = 1.68; 
95% CI, 1.26–2.24).
In our multivariable-adjusted logis-
tic regression analyses, we found that some 
observations unduly influenced the parameter 
estimate for creatinine-corrected urine Cd 
concentrations. In analyses of data from our 
whole study population, we identified five 
observations that were deemed to be influen-
tial data points. When these observations were 
retained in the model, the association between 
urine Cd and periodontal disease remained 
significant (OR = 1.32; 95% CI, 1.06–1.64). 
In our analyses of participants with limited 
tobacco exposure, we excluded six influential 
observations. Retention of these data points 
in the logistic regression model substantially 
altered the association between urine Cd and 
periodontal disease (OR = 1.05; 95% CI, 
0.67–1.64). We provide a detailed discussion 
of our rationale for the identification of outli-
ers and their characteristics [see Supplemental 
Material for details (http://www.ehponline.
org/members/2009/0800312/suppl.pdf)].
Discussion
In the present study, we found that environ-
mental Cd exposure, as measured by creati-
nine-corrected urine Cd concentration, was 
associated with increased odds of prevalent 
periodontal disease in U.S. adults. In examin-
ing this association, we adjusted for smoking 
and several other established risk factors for 
periodontal disease that may potentially con-
found its observed relation to Cd exposure. 
To the best of our knowledge, this is the first 
epidemiologic study to report on the potential 
association between environmental Cd expo-
sure and periodontal disease in U.S. adults.
Our findings are supported by the known 
effects of Cd exposure on bone and other tis-
sues. Chronic low-level Cd exposure has been 
linked to decreased BMD and osteoporosis in 
a number of epidemiologic studies (Åkesson 
et al. 2006; Alfvén et al. 2000; Honda et al. 
2003; Staessen et al. 1999). These results have 
been confirmed in animal experiments where 
administration of low levels of Cd over peri-
ods of up to 24 months resulted in decreased 
BMD and increased incidence of osteoporosis 
(Brzóska and Moniuszko-Jakoniuk 2004). In 
these experiments, the serum concentration 
of cross-linking telopeptide of type 1 collagen 
(a marker of bone resorption) was increased 
whereas the activity of serum alkaline phos-
phatase (a marker of bone formation) was 
decreased, indicating a disturbance of nor-
mal bone metabolism due to Cd exposure. 
Data from a number of laboratory experi-
ments suggest that inflammatory mediators, 
such as prostanoids, cytokines, and MMP, 
may be responsible for these effects. In vitro 
experiments have shown that Cd exposure 
stimulates the production of prostaglandin 
E2 in osteoblast-like cells (Suzuki et al. 1989). 
Similarly, Cd promotes the release of calcium 
from organ cultures of neonatal mouse calva-
ria, and this effect is dependent on the induc-
tion of the prostaglandin-synthesizing enzyme 
cyclooxygenase-2 (Romare and Lundholm 
1999). The effects of Cd on cytokines appear 
to be dose dependent such that low concen-
trations of Cd increase the release of cytokines 
(e.g., interleukin-1 and TNF-α), but at higher 
concentrations this effect is less prominent 
(Marth et al. 2000).
The available evidence thus suggests that 
Cd may further aggravate disturbances in the 
bone remodeling process that are present in 
periodontal disease. Periodontal disease is 
caused by accumulation of plaque bacteria in 
the gingival sulcus and subsequent release of 
lipopolysaccharide and microbial peptides that 
elicit a host inflammatory response (Preshaw 
et al. 2004). With advancing disease, there 
is destruction of periodontal ligament and 
loss of attachment caused primarily by host-
derived enzymes (MMP) and inflammatory 
mediators (prostaglandins and cytokines). 
The latter are also responsible for the stimula-
tion of osteoclasts, which leads to resorption 
of alveolar bone. Given the important role 
of inflammation in periodontal disease, it is 
plausible that environmental factors, such as 
exposure to Cd, that stimulate the release of 
inflammatory mediators may contribute to 
periodontal-disease–related tissue destruction.
Table 2. Multivariable-adjusted prevalence ORs for the presence of periodontal disease for a 3-fold incre-
menta in creatinine-corrected urine Cd concentration: NHANES III (1988–1994).
Logistic regression model  No. of participantsb (cases)  OR (95% CI)
Model type A: adjusted for systemic disorders and missing teethc  
  All participants    
  Excluding five influential observations  5,585 (637)  1.54 (1.26–1.87)
  Including all observations  5,590 (642)  1.32 (1.06–1.64)
  Participants with limited tobacco exposured  
  Excluding six influential observations  1,575 (75)  1.68 (1.26–2.24)
  Including all observations  1,581 (81)  1.05 (0.67–1.64)
Model type B: not adjusted for systemic disorders and missing teethe  
  All participants    
  Excluding five influential observations  6,259 (676)  1.52 (1.25–1.85)
  Including all observations  6,264 (681)  1.32 (1.09–1.62)
  Participants with limited tobacco exposured    
  Excluding six influential observations  1,780 (79)  1.67 (1.26–2.21)
  Including all observations  1,786 (85)  1.04 (0.72–1.50)
aA 3-fold increment in creatinine-corrected Cd concentrations is similar to the increment from the 25th percentile 
(0.18 µg/g) to the 75th percentile (0.63 µg/g) in urinary Cd concentration. bParticipants ≥ 18 years of age. cAdjusted for sex, 
age, education level of household head, race/ethnicity, household poverty status, time since last visit to dentist, missing 
teeth, serum cotinine (loge transformed), pack-years of cigarette smoking, number of cigarette smokers at home, expo-
sure to smoke at work, chewing tobacco use, pipe smoking, cigar smoking, blood lead (loge transformed), diabetes, renal 
dysfunction, BMD, examiner identification number, and survey phase. dParticipants, with serum cotinine concentrations 
≤ 10 ng/mL, who reported never using cigarettes, chewing tobacco, cigars, or pipes and having no smokers at home and 
no exposure to cigarette smoke at work. We retained cotinine concentrations (loge transformed) in the model.eAdjusted 
for same variables as in model type A, except diabetes, BMD, and renal dysfunction, which may not be confounders but 
rather intermediates in the relation of Cd exposure to periodontal disease. We also did not adjust for missing teeth in this 
analysis because tooth loss may be a consequence of periodontal disease rather than a confounder.Cadmium and periodontal disease
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Tobacco smoke contains many chemi-
cals that may elevate the risk for periodontal 
disease (Barbour et al. 1997), and it is also a 
major source of Cd exposure in U.S. adults 
(Paschal et al. 2000). We therefore placed 
particular emphasis on distinguishing the 
relationship between Cd and periodontitis 
from the effects of smoking. We adjusted 
our analy  ses for cigarette smoking using 
self-reported smoking behavior and serum 
cotinine, a biomarker of exposure to tobacco 
smoke. We also used questionnaire-recorded 
responses to identify participants with expo-
sure to cigarette smoke in their home and 
work environment. The relationship between 
creatinine-corrected urinary Cd and peri-
odontal disease remained significant after we 
introduced these variables into our multi-
variable-adjusted logistic regression model. 
Without the inclusion of all tobacco variables 
in our analyses, the association between uri-
nary Cd and periodontal disease was nota-
bly stronger than that reported in Table 2, 
confirming the importance of tobacco expo-
sure in our study. Furthermore, we were con-
cerned that tobacco exposure may contain 
several risk factors for periodontal disease that 
may partially “compete” with Cd, obscur-
ing the observed association between Cd and 
periodontal disease among tobacco users and 
those exposed to high levels of ETS. It is pos-
sible that, among these individuals, other con-
stituents of tobacco smoke may promote the 
development of periodontal disease to such an 
extent that Cd exposure no longer has a sub-
stantial impact on risk. We therefore under-
took separate analyses among participants 
with very low tobacco exposure and found 
that the relationship between urinary Cd con-
centrations and periodontal disease was stron-
ger in this group than among our full study 
population. However, this association was 
strongly influenced by six observations that 
markedly affected the parameter estimates for 
the Cd variable in our regression analyses. We 
therefore recommend caution in interpreting 
the association between Cd and periodontal 
disease observed in low-tobacco–exposed par-
ticipants because this was statistically signifi-
cant only upon removal of three influential 
points (and we also excluded three additional 
outliers). Although these observations repre-
sent a small proportion of cases in the low-
tobacco–exposed subgroup [see Supplemental 
Material for details (http://www.ehponline.
org/members/2009/0800312/suppl.pdf)], it 
is plausible that some residual confounding 
by tobacco exposure remained in our analyses 
and accounts for some or all of the association 
between Cd and periodontal disease.
Environmental lead exposure was also a 
potentially important confounder in our study 
because blood lead levels have been associated 
with periodontal-disease–related bone loss in 
this population (Dye et al. 2002; Saraiva et al. 
2007). Furthermore, lead exposure has been 
linked with increased expression of MMP-9 
(Barbosa et al. 2006), a protease that is also 
elevated in periodontal disease (Söder et al. in 
press). In addition to adjusting for blood lead 
concentrations in our main analyses, we under-
took additional analyses restricted to partici-
pants with blood lead concentrations < 3 µg/dL 
and found that the association between urine 
Cd and periodontal disease was stronger.
The present study is limited primarily 
by its cross-sectional design, which prevents 
us from establishing a temporal relationship 
between Cd exposure and periodontal dis-
ease. However, the use of urinary Cd, which 
is a marker of long-term exposure, allowed 
us to consider the effects of Cd exposure over 
periods on the order of a decade or longer 
(Lauwerys et al. 1994). Furthermore, it is 
unlikely that reverse causality (periodontal dis-
ease affecting levels of Cd in urine) is responsi-
ble for the observed findings. In cross-sectional 
studies that include older adults, as this one 
does, survival to be in the cohort may be influ-
enced by the exposure of interest; if Cd expo-
sure increases the risk of mortality (Nawrot 
et al. 2008), any resulting bias in our findings 
would likely be toward under  estimating Cd’s 
association with periodontal disease. Although 
our study is strengthened by a large sample size 
and the use of detailed measures of a number 
of important covariates, including exposure to 
tobacco smoke, unmeasured or mismeasured 
variables may have confounded the observed 
association between environmental Cd expo-
sure and periodontal disease.
Widespread exposure and increasing 
evidence of systemic health effects at levels 
previously considered unimportant make envi-
ronmental Cd exposure a significant public 
health issue. Although information on the oral 
health effects of this toxicant remains limited, 
our results suggest that Cd exposure may be an 
important risk factor for periodontal disease in 
adults. Prospective epidemiologic studies and 
controlled animal experiments are needed to 
confirm and elucidate the mechanisms behind 
the findings of this study.
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